These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29632990)

  • 1. Hepatopulmonary shunting on Tc99m-MAA liver mapping: correlation with dynamic cross-sectional imaging and description of different shunting patterns.
    Bermo M; Matesan MC; Itani M; Behnia F; Vesselle HJ
    Abdom Radiol (NY); 2018 Nov; 43(11):3001-3008. PubMed ID: 29632990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Hickey R; Kulik L; Desai K; Yang Y; Gates VL; Riaz A; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1213-1222. PubMed ID: 28280976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients.
    Sancho L; Rodriguez-Fraile M; Bilbao JI; Beorlegui Arteta C; Iñarrairaegui M; Moran V; Sangro B
    J Vasc Interv Radiol; 2017 Nov; 28(11):1536-1542. PubMed ID: 28916345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting.
    Gaba RC; Zivin SP; Dikopf MS; Parvinian A; Casadaban LC; Lu Y; Bui JT
    Radiology; 2014 May; 271(2):602-12. PubMed ID: 24533871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization.
    Olorunsola OG; Kohi MP; Behr SC; Kolli PK; Taylor AG; Tong RT; LaBerge JM; Kerlan RK; Fidelman N
    J Vasc Interv Radiol; 2015 Oct; 26(10):1472-8. PubMed ID: 26296737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective Study of Quantitative SPECT/CT for Evaluation of Lung Shunt Fraction Before SIRT of Liver Tumors.
    Dittmann H; Kopp D; Kupferschlaeger J; Feil D; Groezinger G; Syha R; Weissinger M; la Fougère C
    J Nucl Med; 2018 Sep; 59(9):1366-1372. PubMed ID: 29371406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization.
    Gates VL; Singh N; Lewandowski RJ; Spies S; Salem R
    J Nucl Med; 2015 Aug; 56(8):1157-62. PubMed ID: 26089551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic
    Struycken L; Patel M; Kuo P; Hennemeyer C; Woodhead G; McGregor H
    AJR Am J Roentgenol; 2022 Apr; 218(4):728-737. PubMed ID: 34704460
    [No Abstract]   [Full Text] [Related]  

  • 9. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ-level internal dosimetry for intra-hepatic-arterial administration of
    Kappadath SC; Lopez BP
    Med Phys; 2022 Aug; 49(8):5504-5512. PubMed ID: 35612924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative aspects of portal-systemic and arteriovenous shunts within the liver in cirrhosis.
    Ohnishi K; Chin N; Sugita S; Saito M; Tanaka H; Terabayashi H; Saito M; Iida S; Nomura F; Okuda K
    Gastroenterology; 1987 Jul; 93(1):129-34. PubMed ID: 3582900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of
    Allred JD; Niedbala J; Mikell JK; Owen D; Frey KA; Dewaraja YK
    EJNMMI Res; 2018 Jun; 8(1):50. PubMed ID: 29904808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung shunt fraction calculation using
    Georgiou MF; Kuker RA; Studenski MT; Ahlman PP; Witte M; Portelance L
    EJNMMI Res; 2021 Sep; 11(1):96. PubMed ID: 34585259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic hemangiomas with arterioportal shunt: findings at two-phase CT.
    Kim KW; Kim TK; Han JK; Kim AY; Lee HJ; Choi BI
    Radiology; 2001 Jun; 219(3):707-11. PubMed ID: 11376258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Same-Day Repeat Hepatopulmonary Shunt Measurement during Planning Angiography for Hepatic Radioembolization.
    McGregor H; Hill M; Kuo P; Woodhead G; Patel M
    J Vasc Interv Radiol; 2020 Jul; 31(7):1069-1073. PubMed ID: 32439249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
    Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
    J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on
    Kovan B; Denizmen D; Civan C; Kuyumcu S; Isik EG; Has Simsek D; Ozkan ZG; Poyanli A; Demir B; Sanli Y
    Cancer Biother Radiopharm; 2024 Jun; 39(5):330-336. PubMed ID: 38265813
    [No Abstract]   [Full Text] [Related]  

  • 18. Transportal Technetium-99m Labeled Macroaggregated Albumin Scintigraphy to Quantify Occult Intrahepatic Microvascular Portosystemic Shunting.
    De la Garza-Ramos C; Muneer MS; Lewis JT; Harnois DM; Taner CB; Frey GT; Rosser B; Toskich BB
    Radiol Case Rep; 2021 Apr; 16(4):975-978. PubMed ID: 33664925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT.
    Haste P; Tann M; Persohn S; LaRoche T; Aaron V; Mauxion T; Chauhan N; Dreher MR; Johnson MS
    J Vasc Interv Radiol; 2017 May; 28(5):722-730.e1. PubMed ID: 28238581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-labelled macroaggregated albumin (MAA) scintigraphy for planning treatment with 90Y microspheres.
    Lambert B; Mertens J; Sturm EJ; Stienaers S; Defreyne L; D'Asseler Y
    Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2328-33. PubMed ID: 20683591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.